These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 18490370

  • 1. The predictors of local recurrence after radical cystectomy in patients with invasive bladder cancer.
    Ide H, Kikuchi E, Miyajima A, Nakagawa K, Ohigashi T, Nakashima J, Oya M.
    Jpn J Clin Oncol; 2008 May; 38(5):360-4. PubMed ID: 18490370
    [Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy.
    Lotan Y, Gupta A, Shariat SF, Palapattu GS, Vazina A, Karakiewicz PI, Bastian PJ, Rogers CG, Amiel G, Perotte P, Schoenberg MP, Lerner SP, Sagalowsky AI.
    J Clin Oncol; 2005 Sep 20; 23(27):6533-9. PubMed ID: 16116151
    [Abstract] [Full Text] [Related]

  • 3. Prognostic significance of vascular invasion in patients with bladder cancer who underwent radical cystectomy.
    Harada K, Sakai I, Hara I, Eto H, Miyake H.
    Int J Urol; 2005 Mar 20; 12(3):250-5. PubMed ID: 15828951
    [Abstract] [Full Text] [Related]

  • 4. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 20; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 5. Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.
    Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.
    J Urol; 2006 Aug 20; 176(2):493-8; discussion 498-9. PubMed ID: 16813876
    [Abstract] [Full Text] [Related]

  • 6. Radical cystectomy and extended pelvic lymphadenectomy: survival of patients with lymph node metastasis above the bifurcation of the common iliac vessels treated with surgery only.
    Steven K, Poulsen AL.
    J Urol; 2007 Oct 20; 178(4 Pt 1):1218-23; discussion 1223-4. PubMed ID: 17698113
    [Abstract] [Full Text] [Related]

  • 7. Natural history of surgically treated bladder carcinoma with extravesical tumor extension.
    Quek ML, Stein JP, Clark PE, Daneshmand S, Miranda G, Cai J, Groshen S, Lieskovsky G, Quinn DI, Raghavan D, Skinner DG.
    Cancer; 2003 Sep 01; 98(5):955-61. PubMed ID: 12942562
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD, Petrylak DP, Singh P, Bagiella E, O'Toole KM, Benson MC, Olsson CA.
    J Urol; 2000 May 01; 163(5):1413-8. PubMed ID: 10751847
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec 01; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy.
    Mills RD, Turner WH, Fleischmann A, Markwalder R, Thalmann GN, Studer UE.
    J Urol; 2001 Jul 01; 166(1):19-23. PubMed ID: 11435814
    [Abstract] [Full Text] [Related]

  • 14. Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.
    Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC.
    J Urol; 2004 Sep 01; 172(3):878-81. PubMed ID: 15310988
    [Abstract] [Full Text] [Related]

  • 15. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar 01; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

  • 16. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
    Kikuchi E, Fujimoto H, Mizutani Y, Okajima E, Koga H, Hinotsu S, Shinohara N, Oya M, Miki T, Cancer Registration Committee of the Japanese Urological Association.
    Int J Urol; 2009 Mar 01; 16(3):279-86. PubMed ID: 19207609
    [Abstract] [Full Text] [Related]

  • 17. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS, Seo JW, Park SJ, Lee YH, Choi YD, Cho NH, Yang SC, Hong SJ.
    Urol Int; 2009 Mar 01; 82(3):306-11. PubMed ID: 19440019
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Int J Urol; 2008 Apr 01; 15(4):314-8. PubMed ID: 18380818
    [Abstract] [Full Text] [Related]

  • 19. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases.
    Lee PC, Port JL, Paul S, Stiles BM, Altorki NK.
    Ann Thorac Surg; 2009 Jul 01; 88(1):186-92; discussion 192-3. PubMed ID: 19559222
    [Abstract] [Full Text] [Related]

  • 20. Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.
    Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.
    J Urol; 2006 Jun 01; 175(6):2058-62. PubMed ID: 16697803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.